Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Acorn Bioventures has led a series B round for the cancer-focused biopharmaceutical spinout of CU Boulder.

Carisma Therapeutics has increased its series B round to $59m thanks to an extension backed by IP Group, Penn Medicine and 4Bio Capital.

The vehicle charging technology spinout of MIT has secured a further $18m for a Mitsubishi-backed round.

Taiho Ventures co-led a series A round for the MIT spinout, which was incubated by MPM Capital.

The cultured meat product developer has added a $10m tranche of funding to its series B round, five years after being spun out of Maastricht University.

UChicago has once again backed the corner store operator, and the round was co-led by Almanac Insights and Monogram Capital Partners.

Point72 Ventures has led a $90m series C round for Shield AI, whose leadership includes Carnegie Mellon University’s associate research professor Nathan Michael.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

University of Oxford and OSI have both returned for a $95.4m series C round that also included GV and, through the conversion of a note, Eli Lilly.